Calamos Advisors »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Calamos Advisors

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Calamos Advisors from 13F filings

Historical chart of Calamos Advisors investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Calamos Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Calamos Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $68M 59M 1.14
2024-06-30 $77M 59M 1.29
2024-03-31 $70M 59M 1.17
2023-12-31 $60M 60M 1.01
2023-09-30 $67M 60M 1.12

More positions owned by Calamos Advisors

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Palo Alto Networks Note 0.375% 6/0 (Principal)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Visa Com Cl A (V)
UnitedHealth (UNH)

View all positions for Calamos Advisors

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Ing Investment Management
Highbridge Capital Management
Calamos Advisors
Tenor Capital Management
Davidson Kempner Capital Management
Advent Capital Management
Steelhead Partners
Lazard Asset Management
BlackRock
Magnetar Financial
State Street Corporation
OZ Management
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Lord, Abbett & Co
Bnp Paribas Arbitrage, Snc

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1